Table of Contents
1. EXECUTIVE SUMMARY
Overview
- Overview of European Non-Hodgkin' s Lymphoma Therapeutics Market
2. GLOSSARY OF TERMS
List of Terms
3. RESEARCH METHODOLOGY
Research Scope and Objective
4. MARKET OVERVIEW
Introduction
- Disease Characteristics
- Epidemiology
- Risk Factors
- Symptoms
- Classification and Staging
- Major Sub Types
- Current Treatment Regimes
5. INDUSTRY CHALLENGES
Industry Challenges for the European Non-Hodgkin' s Lymphoma Therapeutics Market
- Challenges Faced by Pharmaceutical and Biotechnology Companies
6. TOTAL EUROPEAN MARKET FOR NON-HODGKIN' S LYMPHOMA THERAPEUTICS MARKET
Market Drivers and Restraints
- Market Drivers
- Market Restraints
- Market Engineering Measurement Analysis
7. TOTAL FORECASTS FOR THE EUROPEAN NON-HODGKIN' S THERAPEUTICS MARKET
Forecasts and Pipeline Analysis
- Patient Forecasts
- Revenue Forecasts
- Market Share Analysis
- Pipeline Analysis
8. STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN NON-HODGKIN' S THERAPEUTICS MARKET
Market Engineering Recommendations
- Strategic Recommendations
9. DATABASE OF KEY INDUSTRY PARTICIPANTS
Key Industry Participants
- Key Participants in the Non-Hodgkin' s Lymphoma Market
10. DECISION SUPPORT DATABASES
Databases for Analysis
- Number of Biotechnology Companies
- Private Investment in Biotechnology
- Government R&D Investment in Biotechnology
- Per cent of Government Investment in Biotechnology
- Number of Biotechnology Patents Filed at or Granted by the European Patent
Office
- Number of Biotechnology Patents Granted by the US Patent & Trademark Office
|
Related Report
|
View Cart
